Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Murrell

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Biomedical Physics & Engineering Express|January 24, 2025
External delay and dispersion correction of automatically sampled arterial blood with dual flow ratesBenjamin Brender, Lubna Burki, Josefina Jeon, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 24, 2025
First-in-human PET neuroimaging of [<sup>18</sup>F]OXD-2314Emily Murrell, Lucas Narciso, Kimberly L Desmond, et al.
Nature Communications|June 14, 2024
Ligand-based design of [<sup>18</sup>F]OXD-2314 for PET imaging in non-Alzheimer's disease tauopathiesAnton Lindberg, Emily Murrell, Junchao Tong, et al.
Advanced Therapeutics|May 17, 2021
Targeting glioblastoma using a novel peptide specific to a deglycosylated isoform of brevicanNiklas von Spreckelsen, Colin M Fadzen, Nina Hartrampf, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Biomedical Physics & Engineering Express|January 24, 2025
External delay and dispersion correction of automatically sampled arterial blood with dual flow ratesBenjamin Brender, Lubna Burki, Josefina Jeon, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 24, 2025
First-in-human PET neuroimaging of [<sup>18</sup>F]OXD-2314Emily Murrell, Lucas Narciso, Kimberly L Desmond, et al.
Nature Communications|June 14, 2024
Ligand-based design of [<sup>18</sup>F]OXD-2314 for PET imaging in non-Alzheimer's disease tauopathiesAnton Lindberg, Emily Murrell, Junchao Tong, et al.
Advanced Therapeutics|May 17, 2021
Targeting glioblastoma using a novel peptide specific to a deglycosylated isoform of brevicanNiklas von Spreckelsen, Colin M Fadzen, Nina Hartrampf, et al.
Pageof 2